RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance
Qian Zhang(Brigham and Women's Hospital), Jizong Zhao(Capital Medical University), Chaoxia Lu(Chinese Academy of Medical Sciences & Peking Union Medical College), Rong Wang(Yinchuan First People's Hospital), Yan Zhang(Shenzhen Children's Hospital), Shuo Wang(Kailuan General Hospital), Yaping Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Dong Zhang(Beijing Hospital), Fang Liu(Foshan University), Jian Zhou(Fudan University), Xue Zhang(Shanghai University), Lanbing Yu(Capital Medical University)
Cited by 88
Related Papers
Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment
|MedComm|2021|369
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units
|BMC Gastroenterology|2012|113
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
|Journal of Clinical Investigation|2013|107